Stock KRMD KORU MEDICAL SYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights KORU Medical Systems, Inc.

Equities

KRMD

US7599101026

Market Closed - Nasdaq
Other stock markets
 21:00:00 08/05/2024 BST 		5-day change 1st Jan Change
2.25 USD -0.44% Intraday chart for KORU Medical Systems, Inc. 0.00% -8.35%
05-01 Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Revenue $8.2M, vs. Street Est of $7.5M MT
05-01 Transcript : KORU Medical Systems, Inc., Q1 2024 Earnings Call, May 01, 2024

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Revenue $8.2M, vs. Street Est of $7.5M
MT
KORU Medical Systems, Inc. reaffirms Financial Guidance for the Full Year of 2024
CI
KORU Medical Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
KORU Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
KORU Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q4 Revenue $7.2M, vs. Street Est of $6.9M
MT
KORU Medical Systems, Inc. Provides Earnings Guidance for the Full Year 2024
CI
KORU Medical Systems, Inc. Announces A Feasibility Study to Enter Ambulatory Infusion Settings with A Commercialized Biologic
CI
KORU Medical Systems, Inc. Signs Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for Novel Subcutaneous Immunoglobulin
CI
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q3 Revenue $7M, vs. Street Est of $7.9M
MT
KORU Medical Systems, Inc. Announces Development Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System
CI
KORU Medical Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60 Infusion System With Hizentra 50 ML Prefilled Syringes
CI
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q2 Revenue $6.9M, vs. Street Est of $7.2M
MT
KORU Medical Systems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
KORU Medical Systems, Inc. Updates Revenue Guidance for the Full Year 2023
CI
KORU Medical Systems, Inc. Provides Revenue Guidance for the Full Year 2023
CI
KORU Medical Systems, Inc. Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic
CI
Koru Medical Systems Submits Premarket Notification With US FDA for Use of Freedom60 Infusion System With Hizentra
MT
KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60®? Infusion System with Hizentra®? 50 Ml Preilled Syringes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KRMD Stock
  4. News KORU Medical Systems, Inc.
  5. Highlights